Tuberculosis

Share
Share this

One-third of the world’s population is currently infected with the tuberculosis (TB) bacillus. Every year, nine million people develop active TB and 1.5 million die from it.

TB is spread through the air when infected people cough or sneeze. Not everyone infected with TB becomes ill, but 10 per cent
will develop active TB at some point in their lives. The disease most often affects the lungs. Symptoms include a persistent cough, fever, weight loss, chest pain and breathlessness in the lead-up to death. TB incidence is much higher and is a leading cause of death among people with HIV.

Diagnosis of TB depends on a phlegm sample, which can be difficult to obtain from children. There is a new molecular test that can give results after just two hours, and detect a certain level of drug resistance, but it is costly, depends on a reliable power supply, and still requires a phlegm sample.

A course of treatment for uncomplicated TB takes a minimum of six months. When patients are resistant to the two most powerful first-line antibiotics, they are considered to have multidrug-resistant TB (MDR-TB). MDR-TB is not impossible to treat, but the drug regime is arduous, taking up to two years and causing many side effects. Extensively drug-resistant tuberculosis (XDR-TB) is identified when resistance to second-line drugs develops on top of MDR-TB. The treatment options for XDR-TB are limited.

Vacancy
Regional Advocacy Manager for our TB programs in Central Asia Looking for new professional...
Month in Focus
SYRIA – A humanitairan failure EBOLA - Remain vigilant ETHIOPIA – The plight of women refugees MDR-...
Photo of the week
Tuberculosis (TB) is a big problem in eastern Ukraine , especially in prisons. The official death...
Press release
Urges leadership in all European countries to commit to sending high-level political representation...
Video
Ignored for the past fifty years, the needs of patients suffering from tuberculosis are finally...
Article
Fewer than 1,000 people worldwide have been able to access the two new TB drugs – just a fraction...
Article
Decentralization key for scaling up MDR-TB treatment in Myanmar
Press release
endTB will provide access to new anti-TB drugs for more than 3,000 people and run clinical trials...
Updates
In just the last two weeks, five medical facilities supported by MSF have either been damaged or...
Gallery
MSF has been working in Donetsk since 2011, running a program to treat patients with drug-resistant...
Press release
Successfully restarted primary health care services and emergency referrals for many living in...
Crisis Update
( Russian and Ukrainian versions below) With winter settling in in eastern Ukraine, Médecins Sans...
Month in Focus
Malaria treatment in Liberia, AUVs for TB in PNG, Indirect victims in South Sudan, Chagas in Mexico...
Article
Tuberculosis prevalence is among the highest in the world, with major access challenges
Report
A survey of eight countries reveals that efforts to control the epidemic are out of step with...
Press release
View the full report at the MSF Access Campaign BARCELONA, Spain — Outmoded policies and...

Pages